Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.
BMC Infect Dis. 2024 Sep 19;24(1):1010. doi: 10.1186/s12879-024-09799-8.
The prevalence of biliary tract diseases, which are common gastrointestinal disorders, is steadily rising. If it progresses to sepsis or septic shock, it can endanger the patient's life. Therefore, it is crucial to promptly diagnose bacterial infection in individuals suffering from biliary diseases and comprehend the risk factors associated with infection. The objective of this study was to examine the types of bacteria present in the bile of patients with biliary tract diseases, assess any alterations in their susceptibility to antimicrobial agents, and identify the risk factors contributing to the development of infection in these patients.
From June 2019 to November 2022, 317 patients of biliary tract diseases with positive bile culture were included in this hospital-based descriptive analysis. The hospital's computerized medical records were used to collect data on demographic information (including gender, age, and occupation), laboratory, and clinical findings, physical examination results, comorbidities, basic diseases, treatment history, complications, and in-hospital outcomes. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) principles.
Of the 317 patients with positive biliary tract diseases, 247 had benign diseases and 70 had malignant diseases. Patients with benign disease experienced a higher prevalence of statistically significant symptoms such as abdominal pain (81.4% vs. 57.1%, P = 0.000), nausea (31.2% vs. 14.3%, P = 0.005), vomiting (30.0% vs. 12.9%, P = 0.004), and chills (10.9% vs. 2.9%, P = 0.039), while jaundice (12.6% vs. 37.1%, P = 0.000) was more common in patients with malignant disease. At the species level, Escherichia coli (105; 40.5%), Klebsiella pneumoniae (41; 15.8%), and Pseudomonas aeruginosa (30; 11.6%) were the most commonly found Gram-negative bacterial strains in biliary tract infection. Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were most susceptible to tigecycline, ertapenem and ceftazidime/avibactam, respectively.
Gram-negative bacteria are the most commonly isolated biliary bacteria. Clinical doctors should pay attention to patients with malignant diseases with low hemoglobin, high total bilirubin and high alkaline phosphatase. Carbapenems, tigecycline, and minocycline are the recommended antibiotics for Enterobacteriaceae. In recent years, the proportion of enterococcus has gradually increased, and clinical attention should be paid to enterococcus infection. Linezolid and vancomycin were recommended for the treatment of Enterococci infections. Overall, this work can provide reference for clinical diagnosis, treatment and effective interventions.
胆道疾病是常见的胃肠道疾病,其患病率稳步上升。如果发展为脓毒症或感染性休克,可能会危及患者的生命。因此,及时诊断胆道疾病患者的细菌感染并了解感染相关的危险因素至关重要。本研究旨在研究胆道疾病患者胆汁中存在的细菌类型,评估其对抗菌药物敏感性的变化,并确定导致这些患者发生感染的危险因素。
本医院基于描述性分析纳入了 2019 年 6 月至 2022 年 11 月期间 317 例胆汁培养阳性的胆道疾病患者。使用医院的计算机化病历收集人口统计学信息(包括性别、年龄和职业)、实验室和临床发现、体格检查结果、合并症、基础疾病、治疗史、并发症和住院结局。本研究遵循了《观察性研究的报告规范》(STROBE)原则。
在 317 例胆汁培养阳性的胆道疾病患者中,247 例为良性疾病,70 例为恶性疾病。良性疾病患者出现腹痛(81.4% vs. 57.1%,P=0.000)、恶心(31.2% vs. 14.3%,P=0.005)、呕吐(30.0% vs. 12.9%,P=0.004)和寒战(10.9% vs. 2.9%,P=0.039)等症状的比例更高,而恶性疾病患者更常见黄疸(12.6% vs. 37.1%,P=0.000)。在种水平上,大肠埃希菌(105;40.5%)、肺炎克雷伯菌(41;15.8%)和铜绿假单胞菌(30;11.6%)是胆道感染中最常见的革兰氏阴性细菌株。大肠埃希菌、肺炎克雷伯菌和铜绿假单胞菌对替加环素、厄他培南和头孢他啶/阿维巴坦最敏感。
革兰氏阴性菌是最常见的胆道分离菌。临床医生应注意低血红蛋白、总胆红素和碱性磷酸酶高的恶性疾病患者。对于肠杆菌科,碳青霉烯类、替加环素和米诺环素是推荐的抗生素。近年来,肠球菌的比例逐渐增加,应注意肠球菌感染。治疗肠球菌感染推荐使用利奈唑胺和万古霉素。总的来说,这项工作可以为临床诊断、治疗和有效干预提供参考。